Patients’ and urologists’ preferences for prostate cancer treatment: a discrete choice experiment

被引：0
作者：
E W de Bekker-Grob
M C J Bliemer
B Donkers
M-L Essink-Bot
I J Korfage
M J Roobol
C H Bangma
E W Steyerberg
机构：
[1] Erasmus MC—University Medical Centre Rotterdam,Department of Public Health
[2] PO Box 2040,Department of Business Economics
[3] Rotterdam,Department of Public Health
[4] The Netherlands,Department of Urology
[5] Institute of Transport and Logistics Studies,undefined
[6] University of Sydney,undefined
[7] Erasmus University Rotterdam,undefined
[8] Academic Medical Centre,undefined
[9] University of Amsterdam,undefined
[10] Erasmus MC—University Medical Centre Rotterdam,undefined
来源：
British Journal of Cancer | 2013年 / 109卷
关键词：
prostate cancer treatment; preferences; patients; urologists;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：633 / 640
页数：7
相关论文
共 216 条
[1]  
Aning JJ(2012)Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret Curr Oncol 19 S37-S44
[2]  
Wassersug RJ(2006)Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with U.K. dermatologists Br J Dermatol 155 1236-1241
[3]  
Goldenberg SL(2006)The reasons of general practitioners for promoting colorectal cancer mass screening in France Eur J Health Econ 7 91-98
[4]  
Ashcroft DM(2004)Women and health care professionals’ preferences for Down’s syndrome screening tests: a conjoint analysis study BJOG 111 775-779
[5]  
Seston E(2005)Surgical treatment of localized prostate cancer Acta Oncol 44 599-604
[6]  
Griffiths CE(2009)Preferences of GPs and patients for preventive osteoporosis drug treatment: a discrete-choice experiment Pharmacoeconomics 27 211-219
[7]  
Berchi C(2010)Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening Value Health 13 315-323
[8]  
Dupuis JM(2012)Discrete choice experiments in health economics: a review of the literature Health Econ 21 145-172
[9]  
Launoy G(1997)Modeling valuations for EuroQol health states Med Care 35 1095-1108
[10]  
Bishop AJ(2010)Medical treatment of benign prostatic hyperplasia: physician and patient preferences and satisfaction Int J Clin Pract 64 1425-1435
12345678910